In this issue:
Lipid targets improved on atazanavir
When to start ART?
Early ART = survival advantage
Expand access to ART?
Testosterone beneficial in HIV+ women
PI monotherapy maintains viral suppression
NRTI backbone critical in HAART
Effects of stopping START after birth
Leptin for HIV-associated lipodystrophy?
Please login below to download this issue (PDF)